Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation

Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4‐year‐old girl experiencing early MDS relapse post‐HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted therapies. We underscore...

Descripción completa

Detalles Bibliográficos
Autores principales: Wachter, Franziska, Pikman, Yana, Bledsoe, Jacob, Kapadia, Malika, Baumeister, Susanne, Rowe, Jared, Shimamura, Akiko, Place, Andrew E., Prockop, Susan, Whangbo, Jennifer, Lehmann, Leslie, Horan, John, Pollard, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665583/
https://www.ncbi.nlm.nih.gov/pubmed/38028059
http://dx.doi.org/10.1002/ccr3.8190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665583/
https://www.ncbi.nlm.nih.gov/pubmed/38028059
http://dx.doi.org/10.1002/ccr3.8190

Ejemplares similares